Insider Trading Summary for Travere Therapeutics, Inc. (TVTX): Three Months

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
04-Oct-24 7:15 PM View:	04-Oct-24 Planned Option Sale ($589.10K)	Lyons Gary A Director		Travere Therapeutics, Inc. - TVTX	0% 51.0K	0	0	--	--	Show Txns Hide Txns

30-Sep-24 8:38 PM View:	30-Sep-24 Planned Option Sale ($562.32K)	Meckler Jeffrey A Director		Travere Therapeutics, Inc. - TVTX	0% 81.0K	0	0	--	--	Show Txns Hide Txns

09-Sep-24 9:20 PM View:	09-Sep-24 Sale (Planned) ($50.54K)	Reed Elizabeth E SVP, GC & Corporate Secretary		Travere Therapeutics, Inc. - TVTX	3% 76.27K to 78.63K	0	0	--	--	Show Txns Hide Txns

09-Sep-24 9:20 PM View:	09-Sep-24 Sale (Planned) ($50.54K)	Rote William E. Senior Vice President, R&D		Travere Therapeutics, Inc. - TVTX	3% 82.09K to 84.45K	0	0	--	--	Show Txns Hide Txns

09-Sep-24 9:20 PM View:	09-Sep-24 Sale (Planned) ($243.36K)	Dube Eric M Chief Executive Officer Director		Travere Therapeutics, Inc. - TVTX	3% 350.6K to 361.98K	0	0	--	--	Show Txns Hide Txns

09-Sep-24 9:20 PM View:	09-Sep-24 Sale ($25.24K)	Heerma Peter Chief Commercial Officer		Travere Therapeutics, Inc. - TVTX	4% 103.4K to 107.96K	0	0	--	--	Show Txns Hide Txns

10-Sep-24 4:05 PM View:	10-Sep-24 Sale (Planned) ($8.88K)	Inrig Jula Chief Medical Officer		Travere Therapeutics, Inc. - TVTX	7% 58.07K to 61.95K	0	0	--	--	Show Txns Hide Txns

09-Sep-24 9:20 PM View:	09-Sep-24 Sale ($28.68K)	Cline Christopher R. Chief Financial Officer		Travere Therapeutics, Inc. - TVTX	5% 70.85K to 74.59K	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	0	--